Global Cholesterol Test Market is valued approximately USD 8,537.52 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8% over the forecast period 2022-2029. Cholesterol Test is also known as lipid profile test. This blood test calculates the blood's triglyceride and cholesterol levels. The Cholesterol Test market is expanding because of factors such as rising. Rising prevalence of cardiovascular disease and growing healthcare infrastructure. Since, Cardiovascular is one of the world's fastest-growing chronic diseases. Its prevalence has progressively increased during the last few decades.
According to the World Health Organization, Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Furthermore, geriatric, and obese populations are predisposed to chronic diseases in which one third of these deaths occur prematurely in people under 70 years of age. According to the U.S. Department of Health & Human Services, Centers for Disease Control and Prevention almost 2 in 5 adults in the United States have high cholesterol levels which leads to risk for heart disease and stroke, two major causes of death in the United States. In addition, the leading causes of death globally included heart disease, stroke, and chronic obstructive pulmonary disease. There were 8.89 million deaths from heart disease and about 6.19 million deaths caused by stroke. However, incorrect fasting, drugs, and human error may stifle market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cholesterol Test Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the presence of major pharmaceutical and biopharmaceutical companies within the region. According to the Statista, Pharmaceutical sales revenues in the United States have accounted for half of the global total in recent years. Globally 5 out of the ten leading pharmaceutical companies were from the United States generating a record 55 billion U.S. dollars in 2021. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising population and increasing awareness about healthy lifestyle in the market space.
Major market players included in this report are:
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.,
- Merck & Co., Inc.,
- Abbott Laboratories,
- Randox Laboratories Limited
- Thermo fisher scientific,
- Abcam plc.,
- PerkinElmer, Inc.,
- Diazyme Laboratories, Inc.,
- Fujifilm Holding Corporation
Recent Developments in the Market:
- In December 2022, Merck, and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), announced an exclusive license and collaboration agreement to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer. Under the agreement, Kelun-Biotech has granted Merck exclusive global licenses to research, develop, manufacture, and commercialize multiple investigational preclinical ADC therapies and exclusive options to obtain additional licenses to ADC candidates.
Global Cholesterol Test Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Product Type, Test Type, End User, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
- Test Kits
- Test Strips
- Others
By Test Type:
- Total Cholesterol Test
- High-Density Lipoprotein (HDL) Cholesterol
- Low-Density Lipoprotein (LDL) Cholesterol
- Triglycerides/VLDL Cholesterol Test
By End User:
- Hospitals
- Diagnostic Centers
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
- 1.2.1. Cholesterol Test Market, by Region, 2019-2029 (USD Million)
- 1.2.2. Cholesterol Test Market, by Product Type, 2019-2029 (USD Million)
- 1.2.3. Cholesterol Test Market, by Test Type, 2019-2029 (USD Million)
- 1.2.4. Cholesterol Test Market, by End User, 2019-2029 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Cholesterol Test Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Cholesterol Test Market Dynamics
- 3.1. Cholesterol Test Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Growing healthcare infrastructure
- 3.1.1.2. Rising prevalence of cardiovascular disease
- 3.1.2. Market Challenges
- 3.1.2.1. Incorrect fasting, drugs, and human error
- 3.1.3. Market Opportunities
- 3.1.3.1. Growing demand for enhanced healthcare services
- 3.1.3.2. Growing awareness about healthy lifestyle
Chapter 4. Global Cholesterol Test Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Investment Adoption Model
- 4.5. Analyst Recommendation & Conclusion
- 4.6. Top investment opportunity
- 4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cholesterol Test Market, by Product Type
- 6.1. Market Snapshot
- 6.2. Global Cholesterol Test Market by Product Type, Performance - Potential Analysis
- 6.3. Global Cholesterol Test Market Estimates & Forecasts by Product Type 2019-2029 (USD Million)
- 6.4. Cholesterol Test Market, Sub Segment Analysis
- 6.4.1. Test Kits
- 6.4.2. Test Strips
- 6.4.3. Others
Chapter 7. Global Cholesterol Test Market, by Test Type
- 7.1. Market Snapshot
- 7.2. Global Cholesterol Test Market by Test Type, Performance - Potential Analysis
- 7.3. Global Cholesterol Test Market Estimates & Forecasts by Test Type 2019-2029 (USD Million)
- 7.4. Cholesterol Test Market, Sub Segment Analysis
- 7.4.1. Total Cholesterol Test
- 7.4.2. High-Density Lipoprotein (HDL) Cholesterol
- 7.4.3. Low-Density Lipoprotein (LDL) Cholesterol
- 7.4.4. Triglycerides/VLDL Cholesterol Test
Chapter 8. Global Cholesterol Test Market, by End User
- 8.1. Market Snapshot
- 8.2. Global Cholesterol Test Market by End User, Performance - Potential Analysis
- 8.3. Global Cholesterol Test Market Estimates & Forecasts by End User 2019-2029 (USD Million)
- 8.4. Cholesterol Test Market, Sub Segment Analysis
- 8.4.1. Hospitals
- 8.4.2. Diagnostic Centres
- 8.4.3. Others
Chapter 9. Global Cholesterol Test Market, Regional Analysis
- 9.1. Cholesterol Test Market, Regional Market Snapshot
- 9.2. North America Cholesterol Test Market
- 9.2.1. U.S. Cholesterol Test Market
- 9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
- 9.2.1.2. Test Type breakdown estimates & forecasts, 2019-2029
- 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
- 9.2.2. Canada Cholesterol Test Market
- 9.3. Europe Cholesterol Test Market Snapshot
- 9.3.1. U.K. Cholesterol Test Market
- 9.3.2. Germany Cholesterol Test Market
- 9.3.3. France Cholesterol Test Market
- 9.3.4. Spain Cholesterol Test Market
- 9.3.5. Italy Cholesterol Test Market
- 9.3.6. Rest of Europe Cholesterol Test Market
- 9.4. Asia-Pacific Cholesterol Test Market Snapshot
- 9.4.1. China Cholesterol Test Market
- 9.4.2. India Cholesterol Test Market
- 9.4.3. Japan Cholesterol Test Market
- 9.4.4. Australia Cholesterol Test Market
- 9.4.5. South Korea Cholesterol Test Market
- 9.4.6. Rest of Asia Pacific Cholesterol Test Market
- 9.5. Latin America Cholesterol Test Market Snapshot
- 9.5.1. Brazil Cholesterol Test Market
- 9.5.2. Mexico Cholesterol Test Market
- 9.6. Rest of The World Cholesterol Test Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Danaher Corporation
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Development
- 10.2.2. F. Hoffmann-La Roche Ltd.,
- 10.2.3. Merck & Co., Inc.,
- 10.2.4. Abbott Laboratories,
- 10.2.5. Randox Laboratories Limited
- 10.2.6. Thermo fisher scientific,
- 10.2.7. Abcam plc.,
- 10.2.8. PerkinElmer, Inc.,
- 10.2.9. Diazyme Laboratories, Inc.,
- 10.2.10. Fujifilm Holding Corporation
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption